ISO 10993-1 Biological evaluation of medical devices — Part 1: Evaluation and testing within a risk management process
 |
| Purchase Information |
| Use this form to request purchase information on ISO online subscriptions. |
|
|
Document ISO 10993-1 is offered by IHS as part of an online subscription. This subscription contains many documents on the same topic.
You may also purchase this document alone from the IHS Standards Store.
ISO 10993-1 Document Information:
Title
Biological evaluation of medical devices — Part 1: Evaluation and testing within a risk management process
International Organization for Standardization
Publication Date:
Oct 15, 2009
Scope:
This part of ISO 10993 describes:
— the general principles governing the biological evaluation of
medical devices within a risk management process;
— the general categorization of devices based on the nature and
duration of their contact with the body;
— the evaluation of existing relevant data from all sources;
— the identification of gaps in the available data set on the
basis of a risk analysis;
— the identification of additional data sets necessary to
analyse the biological safety of the medical device;
— the assessment of the biological safety of the medical
device.
This part of ISO 10993 does not cover testing of materials and
devices that do not come into direct or indirect contact with the
patient's body, nor does it cover biological hazards arising from
any mechanical failure. Other parts of ISO 10993 cover specific
tests, as indicated in the Foreword.
About IHS
IHS (NYSE: IHS) is a leading global provider of critical technical information, decision-support tools and related services in a number of industries including aerospace and defense, automotive, construction, electronics, and energy. IHS serves customers ranging from large governments and multinational corporations to smaller companies and technical professionals in more than 100 countries. IHS been in business for more than 45 years and employ more than 2,300 people around the world.
